News

Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...
Eli Lilly receives FDA approval for Amyvid label update
The US Food and Drug Administration (FDA) has granted approval for a label update to Eli Lilly and Company's Amyvid ...
Fierce Pharma1h
Automation, robots and local talent guide the way at Lilly's new $2B-plus North Carolina injectables plant
After blueprinting an injectables facility in North Carolina in 2020, it didn’t take long for Eli Lilly to draw up designs ...
Buy Eli Lilly While The Market Hesitates And Let Time Make You Dominate
Eli Lilly poised for 30-50% growth in 12 months with a strong value and growth nexus. Click here to read more on LLY stock.
3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow
Eli Lilly (NYSE: LLY) has been on fire over the past two years. The drugmaker has generated excellent financial results and ...
Eli Lilly Just Made Another Move to Dominate the Weight Loss Market: Should You Buy the Stock?
Eli Lilly ( LLY 0.90%) is one of the undisputed leaders in the fast-growing market for weight-management medicines. Following ...
5 Revealing Analyst Questions From Eli Lilly’s Q1 Earnings Call
Eli Lilly’s first quarter saw rapid revenue growth, but the market responded negatively due to profit shortfalls and emerging ...
pharmaphorum2h
Nektar eyes pivotal trials for eczema drug cast off by Lilly
Nektar, which accused Lilly of making errors in its analysis of the data, forged ahead with the programme and started the ...